GKCAS 2019 Annual Allergy & Asthma Symposium

April 6, 2019

There is a need for clinicians to stay advanced in their practice on diagnostic strategies and newer treatments of allergic disease. Lectures based on the latest clinical evidence as well as incorporating  practice parameters will allow clinicians to avoid negative consequences as they pertain to patient care --- these include diagnosis and treatment of venom hypersensitivity, the latest research in early introduction of highly allergenic foods, oral desensitization, various protocols for oral desensitization, eosinophilic disorders and mechanism of treatments.

This activity is supported by independent educational grants from Astra Zeneca, Stallergenes Greer and Kaleo, Inc.

Target Audience

Allergists
Allied Health Professionals

Learning Objectives

At the conclusion of this meeting, participants should be able to:

- Discuss Practice Parameter summary statements regarding the management of venom allergy and the use of venom immunotherapy
- Employ the latest recommendations in early introduction of allergenic foods and critique the ability to perform oral desensitization in their practice
- Recognize the clinical presentation of eosinophilic disorders and diagnose their patients appropriately
- Revise how they counsel introduction of solid foods in an infant's diet
- Integrate the material discussed at the meeting into their current practice
 

Additional information
Disclosure: 

GKCAS 2019 Annual Allergy & Asthma Symposium
April 6, 2019
Overland Park, KS

Disclosure Policy
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no financial relationships to disclose must also inform the learners that no financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

David Golden, MD
Independent Contractor/Honorarium: Genentech
Independent Contractor/Contracted Research: Stallergenes/Greer

David Fleischer, MD
Speaker/Honorarium: Abbott, Nestle Nutrition
Consultant/Contracted Research: Aimmune Therapeutics
Consultant/Consulting Fee:  DBV Technologies, Kaleo

The following have no financial relationships to disclose:

Sadia Hayat, MD
Nikita Raje, MD
Nguyen Tran, MD
Neha Patel, MD
Gretchen Poland, RN, FNP-C
Paneez Khoury, MD
Erick Forno, MD

Course summary
Available credit: 
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance
Course opens: 
04/06/2019
Course expires: 
04/06/2021
Event starts: 
04/06/2019 - 7:30am
Event ends: 
04/06/2019 - 1:00pm
Cost:
$0.00
Rating: 
5

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Greater Kansas City Allergy Society (GKCAS).  The American College of Allergy, Asthma and Immunology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of  4 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Available Credit

  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Attendance

Accreditation Period

Course opens: 
04/06/2019
Course expires: 
04/06/2021

Price

Cost:
$0.00
Please login or create an account to take this course.